Bestelling invoeren
Belgium
Orders LinkContactUsLinkComponent
 

Vectors, pBlueScript II

VCSM13 interference resistant helper phage, Interference-resistant helper phage (6 kB, single stranded). Derived from M13 K07 mutant. Carries kanamycin-resistance gene in IG region. High rescue efficiencies with kanamycin selection, size: 1 ml, 1
  STRA200251
Marketsource
 :   STRATAGENE
Vectors, pBlueScript II
  STRA200251
Marketsource
 :  
Vectors, pBlueScript II

VCSM13 interference resistant helper phage, Interference-resistant helper phage (6 kB, single stranded). Derived from M13 K07 mutant. Carries kanamycin-resistance gene in IG region. High rescue efficiencies with kanamycin selection, size: 1 ml, 1

 :  
 
 
   
1 * 1 ST
This product has been blocked by your organization. Please contact your purchasing department for more information
 

The pBluescript II phagemids (plasmids with a phage origin) are cloning vectors designed to simplify commonly used cloning and sequencing procedures, including the construction of nested deletions for DNA sequencing, generation of RNA transcripts in vitro and site-specific mutagenesis and gene mapping.

  • High copy number ColE1-based phagemid
  • Large and versatile polylinker in two orientations, f1 origin available in either (+) or (–) orientation
  • T3 and T7 promoters for in vitro transcription of RNA

The pBluescript II phagemids have an extensive polylinker with 21 unique restriction enzyme recognition sites.

 : For research use only. Not for use in diagnostic procedures.

 

 

  • VPE:
    1
  • Omschrijving:
    VCSM13 interference resistant helper phage, Interference-resistant helper phage (6 kB, single stranded). Derived from M13 K07 mutant. Carries kanamycin-resistance gene in IG region. High rescue efficiencies with kanamycin selection, size: 1 ml

 

Recommendations

Recommendations will be personalized based on your shopping preferences only if you have given your consent by enabling "Enhance my Shopping Experience" on the "Personal Info page".

Otherwise, you will receive generic recommendations.